US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AN2 Therapeutics, Inc.

5.71

+0.09001.60%

Post-market: 5.710.00000.00%19:30 EDT

Volume:451.33K

Turnover:2.59M

Market Cap:215.47M

PE:-5.49

High:5.99

Open:5.64

Low:5.51

Close:5.62

52wk High:7.19

52wk Low:1.00

Shares:37.74M

Float Shares:21.41M

Volume Ratio:1.66

T/O Rate:2.11%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.0401

EPS(LYR):-1.1641

ROE:-50.12%

ROA:-30.80%

PB:2.84

PE(LYR):-4.91

Loading ...

Overview Company News Filings

AN2 Therapeutics Initiated at Buy by Guggenheim

U.S. Research Roundup- Anterix, Fidus Investment, Nextpower

AN2 Therapeutics initiated with a Buy at Guggenheim

One new option listing on July 17th

AN2 Therapeutics shareholders elect Class I directors at annual meeting

AN2 Therapeutics Says Chagas Disease Drug Shows Positive Preclinical, Early Human Data

MT Newswires Live

AN2 Therapeutics says oral AN2-502998 clears T. cruzi in primate study, supports Phase 2 in chronic Chagas disease

AN2 Therapeutics Reports Positive Enabling Data Supporting Advancement of Oral AN2-502998 to Phase 2 Study for Chronic Chagas Disease

THOMSON REUTERS

AN2 Therapeutics - Phase 1 Study Shows Favorable Safety and No Dose-Limiting Toxicities for AN2-502998

THOMSON REUTERS

AN2 Therapeutics CEO presents at Jefferies Global Healthcare Conference

AN2 Therapeutics Inc : Leerink Partners Raises to Outperform From Market Perform; Raises Target Price to $9.00 From $1.00

THOMSON REUTERS

U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology

AN2 Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

AN2 Therapeutics Q1 FY26 net loss narrows 5.83% to $10 million

AN2 Therapeutics Q1 EPS USD -0.29

THOMSON REUTERS

Press Release: AN2 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business and Scientific Highlights

AN2 Therapeutics CEO joins Stifel Virtual Targeted Oncology Forum fireside chat

AN2 Therapeutics Inc expected to post a loss of 23 cents a share - Earnings Preview

AN2 Therapeutics announces annual shareholder meeting

BRIEF-AN2 Therapeutics Enters Open Market Sale Agreement With Jefferies

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/ANTX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ANTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANTX\",,,,,undefined,":{"symbol":"ANTX","market":"US","secType":"STK","nameCN":"AN2 Therapeutics, Inc.","latestPrice":5.71,"timestamp":1790971200000,"preClose":5.62,"halted":0,"volume":451333,"hourTrading":{"tag":"盘后","latestPrice":5.71,"preClose":5.71,"latestTime":"19:30 EDT","volume":3049,"amount":17413.79,"timestamp":1790983804722,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.016014234875444813,"floatShares":21409300,"shares":37736200,"eps":-1.040051,"marketStatus":"Market Closed","change":0.09,"latestTime":"10-02 16:00:00 EDT","open":5.64,"high":5.99,"low":5.51,"amount":2588830.6072781,"amplitude":0.085409,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.040051,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1648180800000,"exchange":"NASDAQ","adjPreClose":5.62,"preHourTrading":{"tag":"盘前","latestPrice":5.62,"preClose":5.62,"latestTime":"05:26 EDT","volume":20,"amount":112.4,"timestamp":1790933199609,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":5.71,"preClose":5.71,"latestTime":"19:30 EDT","volume":3049,"amount":17413.79,"timestamp":1790983804722,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.658014129311905,"impliedVol":1.487,"impliedVolPercentile":0.4727},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANTX\",,,,,undefined,":{"symbol":"ANTX","floatShares":21409300,"roa":"-30.80%","roe":"-50.12%","lyrEps":-1.164094,"volumeRatio":1.658014129311905,"shares":37736200,"dividePrice":0,"high":5.99,"amplitude":0.085409,"preClose":5.62,"low":5.51,"week52Low":1,"pbRate":"2.84","week52High":7.19,"institutionHeld":0,"latestPrice":5.71,"eps":-1.040051,"divideRate":0,"volume":451333,"delay":0,"ttmEps":-1.040051,"open":5.64,"prevYearClose":1.14,"prevWeekClose":4.88,"prevMonthClose":5.32,"prevQuarterClose":5.32,"fiveDayClose":4.88,"twentyDayClose":5.95,"sixtyDayClose":4.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ANTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"ANTX","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2026-05-11","symbol":"ANTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.23,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778472000000,"reportTimeType":"post","actualEps":-0.29},{"market":"US","date":"2026-03-17","symbol":"ANTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.24,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773720000000,"reportTimeType":"post","actualEps":-0.29},{"market":"US","date":"2025-11-12","symbol":"ANTX","fiscalQuarterEnding":"2025/09","expectedEps":-0.23,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2025-08-12","symbol":"ANTX","fiscalQuarterEnding":"2025/06","expectedEps":-0.31,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.21}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ANTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ANTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":2,"updateTime":1784520000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ANTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ANTX","date":"2026-10-02","current":-5.490115,"percent":0.270703,"low":-16.371108,"twenty":-7.48543,"median":-3.144253,"eighty":-0.762774,"high":-0.452319,"avg":-4.012324,"sd":3.609086,"marketCap":212077651},"quantilePoints":[{"date":"2022-03-25","current":-13.396124,"twenty":-13.256944,"median":-13.048173,"eighty":-12.797512,"marketCap":288592704},{"date":"2022-04-01","current":-13.735377,"twenty":-13.389165,"median":-13.082968,"eighty":-13.048173,"marketCap":295901220},{"date":"2022-04-08","current":-13.126462,"twenty":-13.389165,"median":-13.126462,"eighty":-13.048173,"marketCap":282783370},{"date":"2022-04-14","current":-12.195692,"twenty":-13.35611,"median":-13.056872,"eighty":-12.282634,"marketCap":262731799},{"date":"2022-04-22","current":-12.674125,"twenty":-13.265642,"median":-13.043824,"eighty":-12.188734,"marketCap":273038682},{"date":"2022-04-29","current":-13.596196,"twenty":-13.35611,"median":-13.048173,"eighty":-12.282634,"marketCap":292902855},{"date":"2022-05-06","current":-16.371108,"twenty":-13.735377,"median":-13.082968,"eighty":-12.639148,"marketCap":352682772},{"date":"2022-05-13","current":-12.634954,"twenty":-13.707541,"median":-13.048173,"eighty":-12.337661,"marketCap":343038993},{"date":"2022-05-20","current":-7.432326,"twenty":-13.556182,"median":-13.043824,"eighty":-12.180035,"marketCap":201787643},{"date":"2022-05-27","current":-10.426695,"twenty":-13.392645,"median":-13.013378,"eighty":-11.61546,"marketCap":283084780},{"date":"2022-06-03","current":-11.20566,"twenty":-13.378727,"median":-12.769812,"eighty":-10.726847,"marketCap":304233677},{"date":"2022-06-10","current":-6.882048,"twenty":-13.265642,"median":-12.632679,"eighty":-9.433336,"marketCap":186847596},{"date":"2022-06-17","current":-6.081643,"twenty":-13.265642,"median":-12.334802,"eighty":-8.368513,"marketCap":165116619},{"date":"2022-06-24","current":-6.253159,"twenty":-13.196052,"median":-12.186994,"eighty":-7.795366,"marketCap":169773257},{"date":"2022-07-01","current":-5.831517,"twenty":-13.172482,"median":-12.113054,"eighty":-7.105018,"marketCap":158325689},{"date":"2022-07-08","current":-6.424674,"twenty":-13.15991,"median":-11.715613,"eighty":-6.370361,"marketCap":174429895},{"date":"2022-07-15","current":-6.360356,"twenty":-13.1369,"median":-11.019852,"eighty":-6.253159,"marketCap":172683656},{"date":"2022-07-22","current":-5.881542,"twenty":-13.116023,"median":-10.573198,"eighty":-6.184553,"marketCap":159683875},{"date":"2022-07-29","current":-6.117376,"twenty":-13.077749,"median":-9.433336,"eighty":-5.990169,"marketCap":166086752},{"date":"2022-08-05","current":-7.28225,"twenty":-13.051653,"median":-8.550748,"eighty":-5.92728,"marketCap":197713085},{"date":"2022-08-12","current":-11.654946,"twenty":-13.048173,"median":-8.368513,"eighty":-5.964441,"marketCap":376023512},{"date":"2022-08-19","current":-11.973683,"twenty":-13.048173,"median":-8.836607,"eighty":-5.990169,"marketCap":386306920},{"date":"2022-08-26","current":-9.447843,"twenty":-13.042954,"median":-9.447843,"eighty":-6.034477,"marketCap":304815757},{"date":"2022-09-02","current":-7.685769,"twenty":-13.039474,"median":-9.296256,"eighty":-6.073067,"marketCap":247965969},{"date":"2022-09-09","current":-5.683139,"twenty":-13.031725,"median":-8.930422,"eighty":-5.955866,"marketCap":183355118},{"date":"2022-09-16","current":-5.310277,"twenty":-13.017412,"median":-8.532882,"eighty":-5.851527,"marketCap":171325470},{"date":"2022-09-23","current":-6.735572,"twenty":-12.958334,"median":-8.22201,"eighty":-5.820083,"marketCap":217309769},{"date":"2022-09-30","current":-10.452165,"twenty":-12.87166,"median":-8.485618,"eighty":-5.827229,"marketCap":337218196},{"date":"2022-10-07","current":-10.758874,"twenty":-12.827224,"median":-8.662429,"eighty":-5.851527,"marketCap":347113551},{"date":"2022-10-14","current":-10.75286,"twenty":-12.732811,"median":-9.159176,"eighty":-5.887259,"marketCap":346919525},{"date":"2022-10-21","current":-9.868816,"twenty":-12.676035,"median":-9.377444,"eighty":-5.901552,"marketCap":318397617},{"date":"2022-10-28","current":-9.056939,"twenty":-12.658457,"median":-9.321551,"eighty":-5.921562,"marketCap":292204029},{"date":"2022-11-04","current":-9.604204,"twenty":-12.633134,"median":-9.294488,"eighty":-5.955866,"marketCap":309860448},{"date":"2022-11-11","current":-7.870305,"twenty":-12.51788,"median":-9.213301,"eighty":-5.98731,"marketCap":288517524},{"date":"2022-11-18","current":-6.891148,"twenty":-12.343378,"median":-9.131888,"eighty":-6.021613,"marketCap":252622607},{"date":"2022-11-25","current":-5.8326,"twenty":-12.30698,"median":-9.032884,"eighty":-5.94729,"marketCap":213817291},{"date":"2022-12-02","current":-5.102202,"twenty":-12.193952,"median":-8.756244,"eighty":-5.842388,"marketCap":187041623},{"date":"2022-12-09","current":-4.726417,"twenty":-12.185254,"median":-8.550748,"eighty":-5.80579,"marketCap":173265735},{"date":"2022-12-16","current":-5.181593,"twenty":-12.178295,"median":-8.404872,"eighty":-5.725749,"marketCap":189952021},{"date":"2022-12-23","current":-5.043982,"twenty":-12.152199,"median":-8.130215,"eighty":-5.685509,"marketCap":184907330},{"date":"2022-12-30","current":-5.043982,"twenty":-12.047813,"median":-8.043349,"eighty":-5.617123,"marketCap":184907330},{"date":"2023-01-06","current":-5.361546,"twenty":-11.988509,"median":-7.887149,"eighty":-5.544229,"marketCap":196548925},{"date":"2023-01-13","current":-5.642062,"twenty":-11.900765,"median":-7.790914,"eighty":-5.514548,"marketCap":206832334},{"date":"2023-01-20","current":-5.292741,"twenty":-11.857841,"median":-7.780329,"eighty":-5.486455,"marketCap":194026580},{"date":"2023-01-27","current":-6.652975,"twenty":-11.83416,"median":-7.52668,"eighty":-5.481434,"marketCap":243891411},{"date":"2023-02-03","current":-8.256675,"twenty":-11.724707,"median":-7.50379,"eighty":-5.486455,"marketCap":302681464},{"date":"2023-02-10","current":-7.621547,"twenty":-11.591193,"median":-7.550498,"eighty":-5.497097,"marketCap":279398275},{"date":"2023-02-17","current":-7.224591,"twenty":-11.42481,"median":-7.520984,"eighty":-5.503782,"marketCap":264846281},{"date":"2023-02-24","current":-6.409509,"twenty":-11.289301,"median":-7.50379,"eighty":-5.509499,"marketCap":234966188},{"date":"2023-03-03","current":-5.456816,"twenty":-11.208214,"median":-7.426374,"eighty":-5.509499,"marketCap":200041403},{"date":"2023-03-10","current":-4.578221,"twenty":-11.173685,"median":-7.303982,"eighty":-5.480511,"marketCap":167832991},{"date":"2023-03-17","current":-4.684075,"twenty":-11.125722,"median":-7.239128,"eighty":-5.439451,"marketCap":171713523},{"date":"2023-03-24","current":-5.493865,"twenty":-11.125722,"median":-7.16076,"eighty":-5.330785,"marketCap":201399590},{"date":"2023-03-31","current":-4.675853,"twenty":-11.084828,"median":-7.064148,"eighty":-5.270511,"marketCap":191504234},{"date":"2023-04-06","current":-4.230534,"twenty":-11.023486,"median":-6.924927,"eighty":-5.260984,"marketCap":173265735},{"date":"2023-04-14","current":-4.216321,"twenty":-11.019852,"median":-6.821303,"eighty":-5.202027,"marketCap":172683656},{"date":"2023-04-21","current":-4.007874,"twenty":-10.916914,"median":-6.735572,"eighty":-5.163355,"marketCap":164146486},{"date":"2023-04-28","current":-3.789856,"twenty":-10.785335,"median":-6.531871,"eighty":-5.110953,"marketCap":155217351},{"date":"2023-05-04","current":-2.741598,"twenty":-10.756468,"median":-6.516471,"eighty":-5.079973,"marketCap":112284892},{"date":"2023-05-12","current":-2.021591,"twenty":-10.742455,"median":-6.4889,"eighty":-5.044655,"marketCap":98297847},{"date":"2023-05-19","current":-3.128272,"twenty":-10.723989,"median":-6.417091,"eighty":-5.017615,"marketCap":152109119},{"date":"2023-05-26","current":-2.225348,"twenty":-10.658392,"median":-6.345996,"eighty":-4.977293,"marketCap":108205337},{"date":"2023-06-02","current":-2.385158,"twenty":-10.566429,"median":-6.281745,"eighty":-4.901078,"marketCap":115975918},{"date":"2023-06-09","current":-2.560948,"twenty":-10.530346,"median":-6.253159,"eighty":-4.858736,"marketCap":124523557},{"date":"2023-06-16","current":-2.916525,"twenty":-10.482234,"median":-6.179275,"eighty":-4.763467,"marketCap":141813099},{"date":"2023-06-23","current":-2.816644,"twenty":-10.458179,"median":-6.099509,"eighty":-4.692657,"marketCap":136956486},{"date":"2023-06-30","current":-3.356001,"twenty":-10.436883,"median":-6.046964,"eighty":-4.666378,"marketCap":163182196},{"date":"2023-07-07","current":-3.515811,"twenty":-10.412827,"median":-5.988739,"eighty":-4.546389,"marketCap":170952777},{"date":"2023-07-14","current":-3.096311,"twenty":-10.358348,"median":-5.938714,"eighty":-4.379111,"marketCap":150555003},{"date":"2023-07-21","current":-3.096311,"twenty":-10.284978,"median":-5.895835,"eighty":-4.25703,"marketCap":150555003},{"date":"2023-07-28","current":-3.268106,"twenty":-10.193567,"median":-5.832059,"eighty":-4.205213,"marketCap":158908377},{"date":"2023-08-04","current":-3.216168,"twenty":-10.158686,"median":-5.817224,"eighty":-4.029666,"marketCap":156382938},{"date":"2023-08-11","current":-3.356001,"twenty":-10.014353,"median":-5.791146,"eighty":-3.845856,"marketCap":163182196},{"date":"2023-08-18","current":-5.688753,"twenty":-9.981877,"median":-5.731467,"eighty":-3.79935,"marketCap":308944792},{"date":"2023-08-25","current":-8.204932,"twenty":-9.916927,"median":-5.791146,"eighty":-3.845856,"marketCap":445593450},{"date":"2023-09-01","current":-8.226812,"twenty":-9.859194,"median":-5.817224,"eighty":-3.898925,"marketCap":446781699},{"date":"2023-09-08","current":-8.50578,"twenty":-9.820705,"median":-5.831517,"eighty":-3.974712,"marketCap":461931876},{"date":"2023-09-15","current":-7.915024,"twenty":-9.604204,"median":-5.888688,"eighty":-4.007874,"marketCap":429849148},{"date":"2023-09-22","current":-7.554007,"twenty":-9.586163,"median":-5.938714,"eighty":-4.029192,"marketCap":410243036},{"date":"2023-09-29","current":-8.730048,"twenty":-9.561973,"median":-5.988739,"eighty":-4.031561,"marketCap":474111430},{"date":"2023-10-06","current":-8.292451,"twenty":-9.447843,"median":-6.060204,"eighty":-4.121573,"marketCap":450346446},{"date":"2023-10-13","current":-8.068183,"twenty":-9.447843,"median":-6.108187,"eighty":-4.154735,"marketCap":438166892},{"date":"2023-10-20","current":-7.958784,"twenty":-9.433336,"median":-6.21897,"eighty":-4.202436,"marketCap":432225646},{"date":"2023-10-27","current":-8.062713,"twenty":-9.388622,"median":-6.246012,"eighty":-4.20799,"marketCap":437869830},{"date":"2023-11-03","current":-8.204932,"twenty":-9.299901,"median":-6.263879,"eighty":-4.222006,"marketCap":445593450},{"date":"2023-11-10","current":-8.42373,"twenty":-9.245776,"median":-6.345996,"eighty":-4.238114,"marketCap":457475942},{"date":"2023-11-17","current":-8.188416,"twenty":-9.191651,"median":-6.417091,"eighty":-4.251835,"marketCap":488651941},{"date":"2023-11-24","current":-8.592106,"twenty":-9.159176,"median":-6.462436,"eighty":-4.25703,"marketCap":512742511},{"date":"2023-12-01","current":-8.756572,"twenty":-9.148261,"median":-6.515364,"eighty":-4.263696,"marketCap":522557188},{"date":"2023-12-08","current":-9.369582,"twenty":-9.256601,"median":-6.592423,"eighty":-4.286376,"marketCap":559139166},{"date":"2023-12-15","current":-10.181945,"twenty":-9.420585,"median":-6.735572,"eighty":-4.378104,"marketCap":607617721},{"date":"2023-12-22","current":-10.216831,"twenty":-9.539147,"median":-6.886598,"eighty":-4.40653,"marketCap":609699622},{"date":"2023-12-29","current":-10.416184,"twenty":-9.612102,"median":-6.924927,"eighty":-4.479724,"marketCap":621596200},{"date":"2024-01-05","current":-9.638708,"twenty":-9.641698,"median":-7.064148,"eighty":-4.516825,"marketCap":575199546},{"date":"2024-01-12","current":-10.431136,"twenty":-9.849572,"median":-7.123402,"eighty":-4.535879,"marketCap":622488443},{"date":"2024-01-19","current":-9.892883,"twenty":-9.923734,"median":-7.161078,"eighty":-4.541134,"marketCap":590367683},{"date":"2024-01-26","current":-9.912818,"twenty":-9.910825,"median":-7.239128,"eighty":-4.565367,"marketCap":591557341},{"date":"2024-02-02","current":-9.937737,"twenty":-9.925728,"median":-7.28225,"eighty":-4.59301,"marketCap":593044413},{"date":"2024-02-09","current":-9.96764,"twenty":-9.966643,"median":-7.362202,"eighty":-4.656903,"marketCap":594828900},{"date":"2024-02-16","current":-1.918771,"twenty":-9.966643,"median":-7.303982,"eighty":-4.541134,"marketCap":114504563},{"date":"2024-02-23","current":-1.649644,"twenty":-9.962656,"median":-7.2641,"eighty":-4.382132,"marketCap":98444182},{"date":"2024-03-01","current":-1.485178,"twenty":-9.942721,"median":-7.216995,"eighty":-4.255363,"marketCap":88629506},{"date":"2024-03-08","current":-1.465243,"twenty":-9.937737,"median":-7.16076,"eighty":-4.202436,"marketCap":87439848},{"date":"2024-03-15","current":-1.515081,"twenty":-9.928955,"median":-7.0934,"eighty":-4.029192,"marketCap":90413992},{"date":"2024-03-22","current":-1.649644,"twenty":-9.912818,"median":-6.924927,"eighty":-3.837326,"marketCap":98444182},{"date":"2024-03-28","current":-1.60479,"twenty":-9.904844,"median":-6.882048,"eighty":-3.54138,"marketCap":95767452},{"date":"2024-04-05","current":-1.493229,"twenty":-9.894877,"median":-6.735572,"eighty":-3.40709,"marketCap":96659696},{"date":"2024-04-12","current":-1.379706,"twenty":-9.873629,"median":-6.531871,"eighty":-3.34002,"marketCap":89311125},{"date":"2024-04-19","current":-1.094567,"twenty":-9.830327,"median":-6.512717,"eighty":-3.300068,"marketCap":70853492},{"date":"2024-04-26","current":-1.048577,"twenty":-9.7389,"median":-6.435973,"eighty":-3.275297,"marketCap":67876455},{"date":"2024-05-03","current":-1.170453,"twenty":-9.714462,"median":-6.384932,"eighty":-3.243335,"marketCap":75765761},{"date":"2024-05-10","current":-1.138196,"twenty":-9.689543,"median":-6.288891,"eighty":-3.200986,"marketCap":73677728},{"date":"2024-05-17","current":-1.025534,"twenty":-9.683563,"median":-6.253159,"eighty":-3.153842,"marketCap":67711920},{"date":"2024-05-24","current":-0.908072,"twenty":-9.651666,"median":-6.21897,"eighty":-3.096311,"marketCap":59956370},{"date":"2024-05-31","current":-0.899037,"twenty":-9.640702,"median":-6.117376,"eighty":-3.032764,"marketCap":59359789},{"date":"2024-06-07","current":-0.917108,"twenty":-9.626747,"median":-6.070923,"eighty":-2.970061,"marketCap":60552951},{"date":"2024-06-14","current":-0.980356,"twenty":-9.610032,"median":-5.995886,"eighty":-2.875774,"marketCap":64729016},{"date":"2024-06-21","current":-0.95325,"twenty":-9.596988,"median":-5.970211,"eighty":-2.763626,"marketCap":62939274},{"date":"2024-06-28","current":-0.971321,"twenty":-9.576487,"median":-5.902982,"eighty":-2.560948,"marketCap":64132436},{"date":"2024-07-05","current":-1.188174,"twenty":-9.555391,"median":-5.857071,"eighty":-2.458418,"marketCap":78450375},{"date":"2024-07-12","current":-1.165585,"twenty":-9.514113,"median":-5.824371,"eighty":-2.36598,"marketCap":76958923},{"date":"2024-07-19","current":-1.260458,"twenty":-9.453014,"median":-5.802931,"eighty":-2.238133,"marketCap":83223021},{"date":"2024-07-26","current":-1.210763,"twenty":-9.447843,"median":-5.737331,"eighty":-2.128663,"marketCap":79941827},{"date":"2024-08-02","current":-1.165585,"twenty":-9.447142,"median":-5.721772,"eighty":-1.927742,"marketCap":76958923},{"date":"2024-08-09","current":-0.46533,"twenty":-9.442138,"median":-5.694989,"eighty":-1.744863,"marketCap":30723911},{"date":"2024-08-16","current":-0.452319,"twenty":-9.420585,"median":-5.683771,"eighty":-1.649644,"marketCap":29245582},{"date":"2024-08-23","current":-0.507705,"twenty":-9.368585,"median":-5.668525,"eighty":-1.569679,"marketCap":32826674},{"date":"2024-08-30","current":-0.521551,"twenty":-9.363601,"median":-5.629593,"eighty":-1.541673,"marketCap":33721947},{"date":"2024-09-06","current":-0.470781,"twenty":-9.359614,"median":-5.566854,"eighty":-1.505114,"marketCap":30439279},{"date":"2024-09-13","current":-0.480012,"twenty":-9.321551,"median":-5.545658,"eighty":-1.493229,"marketCap":31036128},{"date":"2024-09-20","current":-0.484627,"twenty":-9.274889,"median":-5.510762,"eighty":-1.470227,"marketCap":31334552},{"date":"2024-09-27","current":-0.489243,"twenty":-9.269905,"median":-5.493865,"eighty":-1.445308,"marketCap":31632976},{"date":"2024-10-04","current":-0.493858,"twenty":-9.267426,"median":-5.480973,"eighty":-1.398102,"marketCap":31931401},{"date":"2024-10-11","current":-0.484627,"twenty":-9.213301,"median":-5.440937,"eighty":-1.379706,"marketCap":31334552},{"date":"2024-10-18","current":-0.484627,"twenty":-9.159176,"median":-5.400004,"eighty":-1.260458,"marketCap":31334552},{"date":"2024-10-25","current":-0.493858,"twenty":-9.159176,"median":-5.292741,"eighty":-1.224316,"marketCap":31931401},{"date":"2024-11-01","current":-0.498474,"twenty":-9.104599,"median":-5.27157,"eighty":-1.192692,"marketCap":32229825},{"date":"2024-11-08","current":-0.507705,"twenty":-9.056939,"median":-5.260984,"eighty":-1.175061,"marketCap":32826674},{"date":"2024-11-15","current":-0.492263,"twenty":-9.008828,"median":-5.223935,"eighty":-1.165585,"marketCap":29878890},{"date":"2024-11-22","current":-0.659632,"twenty":-8.984772,"median":-5.186886,"eighty":-1.152032,"marketCap":40037712},{"date":"2024-11-29","current":-0.822079,"twenty":-8.833504,"median":-5.165715,"eighty":-1.14661,"marketCap":49897746},{"date":"2024-12-06","current":-0.708859,"twenty":-8.764395,"median":-5.131312,"eighty":-1.135958,"marketCap":43025601},{"date":"2024-12-13","current":-0.703936,"twenty":-8.75631,"median":-5.107495,"eighty":-1.128429,"marketCap":42726812},{"date":"2024-12-20","current":-0.620251,"twenty":-8.752791,"median":-5.06243,"eighty":-1.10594,"marketCap":37647401},{"date":"2024-12-27","current":-0.708859,"twenty":-8.7388,"median":-5.051921,"eighty":-1.093587,"marketCap":43025601},{"date":"2025-01-03","current":-0.699014,"twenty":-8.706848,"median":-5.044823,"eighty":-1.083887,"marketCap":42428023},{"date":"2025-01-10","current":-0.615329,"twenty":-8.669427,"median":-5.041335,"eighty":-1.044599,"marketCap":37348612},{"date":"2025-01-17","current":-0.625174,"twenty":-8.655656,"median":-5.006933,"eighty":-1.011077,"marketCap":37946190},{"date":"2025-01-24","current":-0.615329,"twenty":-8.642528,"median":-4.99154,"eighty":-0.978098,"marketCap":37348612},{"date":"2025-01-31","current":-0.56118,"twenty":-8.620649,"median":-4.940774,"eighty":-0.957768,"marketCap":34061934},{"date":"2025-02-07","current":-0.531644,"twenty":-8.592106,"median":-4.895785,"eighty":-0.948732,"marketCap":32269201},{"date":"2025-02-14","current":-0.551335,"twenty":-8.592106,"median":-4.864028,"eighty":-0.935179,"marketCap":33464356},{"date":"2025-02-21","current":-0.556257,"twenty":-8.573312,"median":-4.805808,"eighty":-0.928854,"marketCap":33763145},{"date":"2025-02-28","current":-0.56118,"twenty":-8.566482,"median":-4.763467,"eighty":-0.907168,"marketCap":34061934},{"date":"2025-03-07","current":-0.644865,"twenty":-8.539495,"median":-4.726229,"eighty":-0.899037,"marketCap":39141345},{"date":"2025-03-14","current":-0.689168,"twenty":-8.528704,"median":-4.684075,"eighty":-0.782698,"marketCap":41830446},{"date":"2025-03-21","current":-0.718704,"twenty":-8.510156,"median":-4.66401,"eighty":-0.732487,"marketCap":43623179},{"date":"2025-03-28","current":-0.815207,"twenty":-8.48965,"median":-4.562154,"eighty":-0.73741,"marketCap":41837220},{"date":"2025-04-04","current":-0.744829,"twenty":-8.484244,"median":-4.520001,"eighty":-0.742333,"marketCap":38225374},{"date":"2025-04-11","current":-0.750694,"twenty":-8.45484,"median":-4.377097,"eighty":-0.733398,"marketCap":38526361},{"date":"2025-04-17","current":-0.738964,"twenty":-8.433268,"median":-4.263696,"eighty":-0.736426,"marketCap":37924387},{"date":"2025-04-25","current":-0.7331,"twenty":-8.412415,"median":-4.240009,"eighty":-0.733323,"marketCap":37623400},{"date":"2025-05-02","current":-0.715505,"twenty":-8.383057,"median":-4.202436,"eighty":-0.728023,"marketCap":36720438},{"date":"2025-05-09","current":-0.703776,"twenty":-8.368106,"median":-4.076567,"eighty":-0.727235,"marketCap":36118464},{"date":"2025-05-16","current":-0.803022,"twenty":-8.352142,"median":-4.007874,"eighty":-0.727235,"marketCap":36419451},{"date":"2025-05-23","current":-0.789749,"twenty":-8.341681,"median":-3.858652,"eighty":-0.727235,"marketCap":35817476},{"date":"2025-05-30","current":-0.805076,"twenty":-8.337305,"median":-3.749538,"eighty":-0.727235,"marketCap":36512621},{"date":"2025-06-06","current":-0.738541,"twenty":-8.328553,"median":-3.531792,"eighty":-0.727235,"marketCap":33495049},{"date":"2025-06-13","current":-0.751848,"twenty":-8.312143,"median":-3.453864,"eighty":-0.727235,"marketCap":34098563},{"date":"2025-06-20","current":-0.731887,"twenty":-8.285296,"median":-3.37993,"eighty":-0.727235,"marketCap":33193292},{"date":"2025-06-27","current":-0.71858,"twenty":-8.255078,"median":-3.34002,"eighty":-0.72001,"marketCap":32589777},{"date":"2025-07-03","current":-0.69862,"twenty":-8.248692,"median":-3.308058,"eighty":-0.71858,"marketCap":31684506},{"date":"2025-07-11","current":-0.711927,"twenty":-8.237752,"median":-3.300068,"eighty":-0.715505,"marketCap":32288020},{"date":"2025-07-18","current":-0.725234,"twenty":-8.232282,"median":-3.276096,"eighty":-0.715505,"marketCap":32891534},{"date":"2025-07-25","current":-0.731887,"twenty":-8.226812,"median":-3.270104,"eighty":-0.715505,"marketCap":33193292},{"date":"2025-08-01","current":-0.705273,"twenty":-8.204932,"median":-3.244134,"eighty":-0.713781,"marketCap":31986263},{"date":"2025-08-08","current":-0.71858,"twenty":-8.204932,"median":-3.210175,"eighty":-0.711927,"marketCap":32589777},{"date":"2025-08-15","current":-0.771244,"twenty":-8.199462,"median":-3.188201,"eighty":-0.711927,"marketCap":28829104},{"date":"2025-08-22","current":-0.811451,"twenty":-8.188416,"median":-3.162232,"eighty":-0.711927,"marketCap":30332043},{"date":"2025-08-29","current":-0.804141,"twenty":-8.18787,"median":-3.120282,"eighty":-0.713781,"marketCap":30058781},{"date":"2025-09-05","current":-0.921107,"twenty":-8.185512,"median":-3.096311,"eighty":-0.714959,"marketCap":34430967},{"date":"2025-09-12","current":-0.928417,"twenty":-8.183731,"median":-3.036031,"eighty":-0.715455,"marketCap":34704229},{"date":"2025-09-19","current":-0.943038,"twenty":-8.171471,"median":-3.008415,"eighty":-0.715505,"marketCap":35250752},{"date":"2025-09-26","current":-0.906486,"twenty":-8.162634,"median":-2.968463,"eighty":-0.715505,"marketCap":33884444},{"date":"2025-10-03","current":-0.935727,"twenty":-8.156796,"median":-2.88656,"eighty":-0.717965,"marketCap":34977491},{"date":"2025-10-10","current":-0.906486,"twenty":-8.151327,"median":-2.842613,"eighty":-0.71858,"marketCap":33884444},{"date":"2025-10-17","current":-0.862624,"twenty":-8.145857,"median":-2.741598,"eighty":-0.71858,"marketCap":32244874},{"date":"2025-10-24","current":-0.855313,"twenty":-8.140387,"median":-2.608584,"eighty":-0.71858,"marketCap":31971613},{"date":"2025-10-31","current":-0.906486,"twenty":-8.138721,"median":-2.541748,"eighty":-0.71858,"marketCap":33884444},{"date":"2025-11-07","current":-0.818761,"twenty":-8.134774,"median":-2.431944,"eighty":-0.71858,"marketCap":30605304},{"date":"2025-11-14","current":-0.826072,"twenty":-8.105379,"median":-2.385158,"eighty":-0.71858,"marketCap":30878566},{"date":"2025-11-21","current":-0.870776,"twenty":-8.0895,"median":-2.290271,"eighty":-0.71858,"marketCap":29594185},{"date":"2025-11-28","current":-0.878839,"twenty":-8.087308,"median":-2.239332,"eighty":-0.718654,"marketCap":29868206},{"date":"2025-12-05","current":-0.858682,"twenty":-8.080228,"median":-2.177405,"eighty":-0.718704,"marketCap":29183155},{"date":"2025-12-12","current":-0.959466,"twenty":-8.07122,"median":-2.079522,"eighty":-0.718704,"marketCap":32608408},{"date":"2025-12-19","current":-0.919152,"twenty":-8.068254,"median":-1.94369,"eighty":-0.722622,"marketCap":31238307},{"date":"2025-12-26","current":-0.919152,"twenty":-8.065995,"median":-1.918771,"eighty":-0.725234,"marketCap":31238307},{"date":"2026-01-02","current":-0.919152,"twenty":-8.061619,"median":-1.814111,"eighty":-0.725634,"marketCap":31238307},{"date":"2026-01-09","current":-1.064281,"twenty":-8.056565,"median":-1.659612,"eighty":-0.727235,"marketCap":36170671},{"date":"2026-01-16","current":-1.007842,"twenty":-8.046873,"median":-1.649644,"eighty":-0.727235,"marketCap":34252530},{"date":"2026-01-23","current":-0.975591,"twenty":-8.018954,"median":-1.599806,"eighty":-0.727235,"marketCap":33156449},{"date":"2026-01-30","current":-0.911089,"twenty":-8.018954,"median":-1.561041,"eighty":-0.727235,"marketCap":30964287},{"date":"2026-02-06","current":-0.85465,"twenty":-8.018336,"median":-1.548364,"eighty":-0.727235,"marketCap":29046145},{"date":"2026-02-13","current":-0.846588,"twenty":-8.008014,"median":-1.522557,"eighty":-0.728549,"marketCap":28772125},{"date":"2026-02-20","current":-0.878839,"twenty":-7.997233,"median":-1.50013,"eighty":-0.731219,"marketCap":29868206},{"date":"2026-02-27","current":-0.85465,"twenty":-7.965935,"median":-1.493229,"eighty":-0.731887,"marketCap":29046145},{"date":"2026-03-06","current":-1.378728,"twenty":-7.954408,"median":-1.485178,"eighty":-0.731887,"marketCap":46857461},{"date":"2026-03-13","current":-4.38613,"twenty":-7.953314,"median":-1.493229,"eighty":-0.731887,"marketCap":149067010},{"date":"2026-03-20","current":-3.046054,"twenty":-7.948938,"median":-1.50013,"eighty":-0.731887,"marketCap":107141913},{"date":"2026-03-27","current":-3.688739,"twenty":-7.933429,"median":-1.530033,"eighty":-0.731887,"marketCap":129747713},{"date":"2026-04-02","current":-3.525249,"twenty":-7.927508,"median":-1.548364,"eighty":-0.731887,"marketCap":123997122},{"date":"2026-04-10","current":-3.116525,"twenty":-7.925964,"median":-1.561041,"eighty":-0.732615,"marketCap":109620644},{"date":"2026-04-17","current":-3.212452,"twenty":-7.9194,"median":-1.599806,"eighty":-0.7331,"marketCap":112994780},{"date":"2026-04-24","current":-4.379966,"twenty":-7.908405,"median":-1.649644,"eighty":-0.7331,"marketCap":154060932},{"date":"2026-05-01","current":-4.656273,"twenty":-7.894202,"median":-1.659612,"eighty":-0.733323,"marketCap":163779729},{"date":"2026-05-08","current":-4.70744,"twenty":-7.877253,"median":-1.829062,"eighty":-0.736426,"marketCap":165579507},{"date":"2026-05-15","current":-4.833714,"twenty":-7.86479,"median":-1.923755,"eighty":-0.738483,"marketCap":167019328},{"date":"2026-05-22","current":-5.094151,"twenty":-7.847513,"median":-2.027584,"eighty":-0.738541,"marketCap":176018215},{"date":"2026-05-29","current":-4.646199,"twenty":-7.819433,"median":-2.133458,"eighty":-0.738541,"marketCap":160540130},{"date":"2026-06-05","current":-4.344092,"twenty":-7.78668,"median":-2.225348,"eighty":-0.73871,"marketCap":150101422},{"date":"2026-06-12","current":-4.635782,"twenty":-7.780329,"median":-2.261305,"eighty":-0.738964,"marketCap":160180175},{"date":"2026-06-18","current":-5.104569,"twenty":-7.77773,"median":-2.29857,"eighty":-0.739835,"marketCap":176378170},{"date":"2026-06-26","current":-5.357655,"twenty":-7.751023,"median":-2.385158,"eighty":-0.743317,"marketCap":185123067},{"date":"2026-07-02","current":-4.899023,"twenty":-7.685769,"median":-2.421115,"eighty":-0.743317,"marketCap":169275956},{"date":"2026-07-10","current":-4.826059,"twenty":-7.621547,"median":-2.531372,"eighty":-0.744829,"marketCap":166754825},{"date":"2026-07-17","current":-4.867753,"twenty":-7.619647,"median":-2.560948,"eighty":-0.744829,"marketCap":168195471},{"date":"2026-07-24","current":-5.128339,"twenty":-7.614177,"median":-2.722625,"eighty":-0.745194,"marketCap":177199512},{"date":"2026-07-31","current":-5.555701,"twenty":-7.577731,"median":-2.806656,"eighty":-0.749594,"marketCap":191966138},{"date":"2026-08-07","current":-6.33746,"twenty":-7.564385,"median":-2.880568,"eighty":-0.750694,"marketCap":218978258},{"date":"2026-08-14","current":-6.220716,"twenty":-7.555871,"median":-2.938499,"eighty":-0.751617,"marketCap":225662697},{"date":"2026-08-21","current":-6.023068,"twenty":-7.536702,"median":-2.976453,"eighty":-0.751848,"marketCap":218492812},{"date":"2026-08-28","current":-5.971055,"twenty":-7.523426,"median":-3.031586,"eighty":-0.751848,"marketCap":216606000},{"date":"2026-09-04","current":-6.189508,"twenty":-7.521025,"median":-3.036382,"eighty":-0.755617,"marketCap":224530610},{"date":"2026-09-11","current":-5.919043,"twenty":-7.514633,"median":-3.04876,"eighty":-0.757725,"marketCap":214719188},{"date":"2026-09-18","current":-5.097242,"twenty":-7.506434,"median":-3.096311,"eighty":-0.758502,"marketCap":184907561},{"date":"2026-09-25","current":-5.08684,"twenty":-7.495053,"median":-3.116525,"eighty":-0.760855,"marketCap":184530198},{"date":"2026-10-02","current":-5.846225,"twenty":-7.48543,"median":-3.144253,"eighty":-0.762774,"marketCap":212077651}],"updateTime":1791043865401},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ANTX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2652139952","title":"AN2 Therapeutics Initiated at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2652139952","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652139952?lang=en_us&edition=fundamental","pubTime":"2026-07-20 20:14","pubTimestamp":1784549640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ANTX/analyst-ratings(END) Dow Jones NewswiresJuly 20, 2026 08:14 ET","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LENZ","BK4007","BK4539","ANTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652293628","title":"U.S. Research Roundup- Anterix, Fidus Investment, Nextpower","url":"https://stock-news.laohu8.com/highlight/detail?id=2652293628","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652293628?lang=en_us&edition=fundamental","pubTime":"2026-07-20 15:39","pubTimestamp":1784533199,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Anterix, Fidus Investment, NextpowerJuly 20 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Anterix","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nL4N43M0FL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BETZ","BBIO","RRX","POOL","KMT","FDUS","KNSL","TKR","NPO","TMUS","AIG","ZAP","ATAI","NXT","ED","BX","IAT","CMCSA","PLNT","AEP","FRVO","TFC","ATEX","IAK","FE","ICLN","ITA","ROK","TRV","MNST","ANTX","FITB","MWH","ELOX","T","CHTR","GE","DFEN","ES","PLMR","VOX","ENPH","VZ","KBWP","RSI","KKR","VCLN","EXI","IPGP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652795263","title":"AN2 Therapeutics initiated with a Buy at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2652795263","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652795263?lang=en_us&edition=fundamental","pubTime":"2026-07-20 08:50","pubTimestamp":1784508604,"startTime":"0","endTime":"0","summary":"Guggenheim initiated coverage of AN2 Therapeutics (ANTX) with a Buy rating and $9 price target Published first on TheFly – the ultimate source for ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/an2-therapeutics-initiated-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/an2-therapeutics-initiated-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","ANTX","BK4139","BK4007","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652283964","title":"One new option listing on July 17th","url":"https://stock-news.laohu8.com/highlight/detail?id=2652283964","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652283964?lang=en_us&edition=fundamental","pubTime":"2026-07-17 20:35","pubTimestamp":1784291759,"startTime":"0","endTime":"0","summary":"New option listings for July 17th include AN2 Therapeutics Inc (ANTX). Published first on TheFly – the ultimate source for real-time, market-moving...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/one-new-option-listing-on-july-17th-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/one-new-option-listing-on-july-17th-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ANTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642469544","title":"AN2 Therapeutics shareholders elect Class I directors at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2642469544","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642469544?lang=en_us&edition=fundamental","pubTime":"2026-06-09 18:01","pubTimestamp":1780999303,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics held its annual shareholder meeting on June 3, 2026.Stockholders backed the selection of three Class I director nominees to serve through the 2029 annual meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AN2 Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 09, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDL12KXjt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640715275","title":"AN2 Therapeutics Says Chagas Disease Drug Shows Positive Preclinical, Early Human Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2640715275","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640715275?lang=en_us&edition=fundamental","pubTime":"2026-06-04 20:04","pubTimestamp":1780574643,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics  said Thursday its experimental drug, AN2-502998, to treat chronic Chagas disease caused by infection with the parasite T. cruzi showed efficacy in a nonhuman primate study and was generally well tolerated in a Phase 1 study in healthy volunteers.The drug developer said a 28-day treatment led to 100% elimination of the parasite, with effects lasting four months after treatment ended in non-human primates with naturally acquired infection.The company said the exposure levels required in animals are achievable in humans.In a phase 1 study in healthy volunteers, multiple ascending doses were generally well tolerated and showed drug levels consistent with those linked to efficacy in animal studies, it added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","LENZ","BK4007","ANTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640510991","title":"AN2 Therapeutics says oral AN2-502998 clears T. cruzi in primate study, supports Phase 2 in chronic Chagas disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2640510991","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640510991?lang=en_us&edition=fundamental","pubTime":"2026-06-04 19:01","pubTimestamp":1780570870,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics reported positive enabling data for oral AN2-502998, supporting advancement into a Phase 2 study for chronic Chagas disease.Results have already been presented from a nonhuman primate study showing parasite elimination that persisted for months post-treatment.A completed Phase 1 first-in-human study indicated the drug was generally well tolerated, supporting continued development.The company plans to start a Phase 2 proof-of-concept trial late this year, targeting adults with chronic infection.The program aims to address a market with no FDA-approved adult treatment, positioning AN2-502998 as a potential first-in-class option.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AN2 Therapeutics Inc. published the original c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL6qhglp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640151796","title":"AN2 Therapeutics Reports Positive Enabling Data Supporting Advancement of Oral AN2-502998 to Phase 2 Study for Chronic Chagas Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2640151796","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640151796?lang=en_us&edition=fundamental","pubTime":"2026-06-04 19:00","pubTimestamp":1780570802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nTUA669TDV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640115172","title":"AN2 Therapeutics - Phase 1 Study Shows Favorable Safety and No Dose-Limiting Toxicities for AN2-502998","url":"https://stock-news.laohu8.com/highlight/detail?id=2640115172","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640115172?lang=en_us&edition=fundamental","pubTime":"2026-06-04 19:00","pubTimestamp":1780570802,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nTUA669TDV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637838089","title":"AN2 Therapeutics CEO presents at Jefferies Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2637838089","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637838089?lang=en_us&edition=fundamental","pubTime":"2026-05-21 19:00","pubTimestamp":1779361220,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics will present at the 2026 Jefferies Global Healthcare Conference on June 4, 2026 at 12:50 p.m. ET.Eric Easom, co-founder, chairman, president and CEO, is scheduled to deliver the presentation.Management will also hold one-on-one meetings during the conference.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AN2 Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on May 21, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL2gP8lW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635616713","title":"AN2 Therapeutics Inc : Leerink Partners Raises to Outperform From Market Perform; Raises Target Price to  $9.00 From $1.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2635616713","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635616713?lang=en_us&edition=fundamental","pubTime":"2026-05-14 18:06","pubTimestamp":1778753191,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nFWN41R0V0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ANTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635358799","title":"U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2635358799","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635358799?lang=en_us&edition=fundamental","pubTime":"2026-05-14 15:24","pubTimestamp":1778743446,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Cisco, DTE Energy, Marvell Technology May 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cisc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL4N41R0NP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLH","AKAM","AVTX","MRVL","DLLL","CARR","CVNX","CSCO","CVNY","CIFR","BXP","CMP","ASTH","DTE","CPT","CMS","DOCS","ASO","ARVN","CAVA","ANTX","ABBV","ATLC","AVB","CGON","MVLL","CSCS","CIFU","ET","CMC","DECK","APGE","CSCL","DELL","CORZ","ARMK","AFRU","DMRA","AMGN","DT","ANDG","AFRM","CVNA","AN","AEE","CIFG","CSR","EBAY","CAKE","MRVU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634258103","title":"AN2 Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2634258103","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634258103?lang=en_us&edition=fundamental","pubTime":"2026-05-12 05:01","pubTimestamp":1778533295,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryAN2 Therapeutics Inc ANTX.OQ reported a quarterly adjusted loss of 29 cents per share for the quarter ended March ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nL8N41O2L3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634232594","title":"AN2 Therapeutics Q1 FY26 net loss narrows 5.83% to $10 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2634232594","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634232594?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:02","pubTimestamp":1778529746,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics posted a Q1 net loss of USD 10 million, narrowing from USD 10.6 million a year earlier; loss per share improved to USD 0.29 from USD 0.35.R&D spending fell to USD 6.7 million from USD 7.7 million, while G&A was flat at USD 3.8 million.Interest income slipped to USD 0.5 million from USD 0.9 million on lower average cash balances and lower interest rates.Cash, cash equivalents and investments totaled USD 85.3 million at March 31, following a USD 40 million private placement; cash runway projected into 2029.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AN2 Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on May 11, 2026, and is solely responsible for the information co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDLb37MLr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634232329","title":"AN2 Therapeutics Q1 EPS USD -0.29","url":"https://stock-news.laohu8.com/highlight/detail?id=2634232329","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634232329?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:01","pubTimestamp":1778529660,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nPLX8BB9EA:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634232680","title":"Press Release: AN2 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business and Scientific Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2634232680","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634232680?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:01","pubTimestamp":1778529660,"startTime":"0","endTime":"0","summary":"Oral epetraborole program in polycythemia vera advancing toward Phase 2. Phase 2 investigator-initiated trial with epetraborole for M. abscessus lung disease underway. Data expected in 2Q/2026 from two studies of oral AN2-502998, under development for chronic Chagas disease: a Phase 1 first-in-human clinical trial and a non-human primate efficacy study. Declared ENPP1 candidate for solid tumors advancing from early research into development. AN2 Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry platform, today reported financial results for the first quarter ended March 31, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","BK4139","ANTX","IE00BHPRN162.USD","LU2237443978.SGD","LU2237443622.USD","LU0170899867.USD","CMC","LU2237443549.SGD","LU0149725797.USD","BK4225","LU0882574139.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","NHP","BK4007","LU0267386448.USD","LU2237443382.USD","LU2237443465.HKD","LENZ","IE00B1BXHZ80.USD","LU1363072403.SGD","LU0971096721.USD","LU2746668461.USD","LU2237443895.HKD","LU2746668974.SGD","IE00BFXG1179.USD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633176854","title":"AN2 Therapeutics CEO joins Stifel Virtual Targeted Oncology Forum fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2633176854","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633176854?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:02","pubTimestamp":1778184169,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics scheduled to join 2026 Stifel Virtual Targeted Oncology Forum on May 19, 2026.Management also set to hold 1x1 meetings during forum.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL9ckcdR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007","BK4127","SF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631652328","title":"AN2 Therapeutics Inc  expected to post a loss of 23 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2631652328","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631652328?lang=en_us&edition=fundamental","pubTime":"2026-04-30 04:02","pubTimestamp":1777492932,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics Inc  expected to post a loss of23cents a share - Earnings Preview AN2 Therapeutics Inc ANTX.OQ ANTX.O is expected to  show no change in quarterly revenue when it reports  results on M","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nL8N41C394:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629027274","title":"AN2 Therapeutics announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2629027274","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629027274?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:07","pubTimestamp":1776888442,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics scheduled 2026 annual stockholders meeting for June 3 in Menlo Park, California.Shareholders will vote on election of three Class I director nominees: Kabeer Aziz, Gilbert Lynn Marks, Rob Readnour.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AN2 Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 22, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL1ZL1XJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629177610","title":"BRIEF-AN2 Therapeutics Enters Open Market Sale Agreement With Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2629177610","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629177610?lang=en_us&edition=fundamental","pubTime":"2026-04-21 04:35","pubTimestamp":1776717349,"startTime":"0","endTime":"0","summary":"BRIEF-AN2 Therapeutics Enters Open Market Sale Agreement With Jefferies April 20  - AN2 Therapeutics Inc ANTX.O:AN2 THERAPEUTICS INC - ENTERS OPEN MARKET SALE AGREEMENT WITH JEFFERIES LLC DATED APRIL 9, 2026 - SEC FILINGAN2 THERAPEUTICS INC - MAY OFFER AND SELL COMMON STOCK UP TO $80 MILLION THROUGH JEFFERIES - SEC FILINGSource text: [ID:n0001193125-26-164095]Further company coverage: ANTX.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nFWN4130WO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":49,"code":"91000000","status":"200"}]}}